Miglustat in Niemann-Pick Type C Disease

NCT00517153 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Niemann-Pick Type C Disease

Interventions

DRUG: miglustat

Sponsor

Actelion